Eisai’s Americas operations are overseen by Eisai Inc., a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. The company’s key areas of commercial focus include oncology and specialty care.
Eisai Co., Ltd., the parent company of all Eisai group companies, is headquartered in Tokyo, Japan. Eisai Co., Ltd. is a research-based human health care (hhc) company that discovers, develops, and markets pharmaceutical products throughout the world. With over 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Oncology and Neurology.
As a global pharmaceutical company, our mission extends to patients around the world through our investment and participation in partnership-based initiatives to improve access to medicines in developing and emerging countries.
For more information about Eisai Co., Ltd., please visit www.eisai.com.